Black Patients More Likely to Trust Medical Videos When Black Doctor, Patient Is in It
THURSDAY, July 20, 2023 (HealthDay News) — The need to increase racial diversity among U.S. health care providers is important for many reasons. Among them, Black patients are more likely to believe Black physicians or patients than sources who are w…
Learn MoreProstate Biopsy: What It Is, How to Prepare, Side Effects, Recovery & Results
The American Cancer Society estimates that 288,300 new cases of prostate cancer will be diagnosed in 2023. While the overall 5-year survival rate is 97%, that number goes down significantly if the cancer has spread to distant parts of the body.Prostat…
Learn MoreThe Silent Killer: What Causes Prostate Cancer?
In 2023 alone, 288,300 new cases of prostate cancer will be diagnosed in the United States, according to the American Cancer Society. And while that number might not seem all that high considering the U.S. population, 34,700 deaths will be related to …
Learn MoreThe Prostate Cancer Symptoms You Should Know
While prostate cancer affects about 1 in 8 men, when it’s caught early, there’s a 99% survival rate, according to Cancer.org. That’s why early-stage detection is so important.The higher the stage number, the more advanced the disease. Learn from the e…
Learn MoreNew Type of Treatment Tackles Tough-to-Treat Prostate Cancer
THURSDAY, July 13, 2023 (HealthDay News) — A preclinical study offers a potential new therapy for treatment-resistant prostate cancer, offering new hope for men with the disease.The study used the chemotherapy drug cisplatin, administered orally, to …
Learn MoreIndigenous Men Less Likely to Receive PSA Testing
MONDAY, July 10, 2023 (HealthDay News) — Indigenous men are less likely to receive prostate-specific antigen (PSA) testing and are more likely to be diagnosed with higher-risk prostate cancer, according to a study published online July 10 in Cancer.A…
Learn MoreAmerican Indian/Alaska Native Men Less Likely to Receive Prostate Screening
MONDAY, July 3, 2023 (HealthDay News) — American Indian/Alaska Native (AI/AN) men are less likely to receive a prostate-specific antigen test (PSAT) and/or digital rectal examination (DRE) during physician visits to nonfederal clinics, according to a…
Learn MoreStaying Fit Lowers a Man’s Cancer Risk, Study Confirms
MONDAY, July 3, 2023 (HealthDay News) — A man’s cardio fitness might influence whether he’ll develop — or survive — three of the most common cancers in males, a new Swedish study reports.Higher levels of cardio fitness are associated with a signifi…
Learn MoreFDA Approves Talzenna for Metastatic, Castration-Resistant Prostate Cancer
MONDAY, June 26, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Talzenna (talazoparib) with enzalutamide for homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC).The ap…
Learn MoreASCO: Drug Combo Ups Progression-Free Survival for Metastatic Prostate Cancer
THURSDAY, June 8, 2023 (HealthDay News) — For patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), according to a study published…
Learn More